Literature DB >> 3124172

Dopaminergic D-1 receptors: essential role in morphine-induced hypermotility.

R Longoni1, L Spina, G Di Chiara.   

Abstract

Administration of morphine HCl (20 mg/kg SC) to male C57Bl/6 mice evoked hypermotility. Pretreatment with low doses of the specific D-1 antagonist SCH 23390 (0.006, 0.012, 0.025 mg/kg SC) dose-dependently inhibited morphine-evoked hypermotility. The results suggest that dopamine is the essential mediator of opiate hypermotility and indicate that D-1 receptors play an important role in this effect.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3124172     DOI： 10.1007/bf00187265

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  11 in total

1.  Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.

Authors:  G Di Chiara; L Vargiu; M L Porceddu; R Longoni; A Mulas; G L Gessa
Journal:  Adv Biochem Psychopharmacol       Date:  1977

2.  Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat.

Authors:  F J Vaccarino; M Amalric; N R Swerdlow; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1986-01       Impact factor: 3.533

3.  Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

4.  Neuroanatomical focus for morphine and enkephalin-induced hypermotility.

Authors:  A Pert; C Sivit
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

5.  SCH 23390 - the first selective dopamine D-1 antagonist.

Authors:  J Hyttel
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

6.  Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

Authors:  W Billard; V Ruperto; G Crosby; L C Iorio; A Barnett
Journal:  Life Sci       Date:  1984-10-29       Impact factor: 5.037

7.  Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

Authors:  P Leone; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-03-17       Impact factor: 4.432

8.  Monoamine mediation of the morphine-induced activation of mice.

Authors:  B J Carroll; P T Sharp
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

9.  Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

10.  The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.

Authors:  J Arnt; J Hyttel; J J Larsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1984-11
View more
  7 in total

1.  D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse.

Authors:  S Cabib; C Castellano; V Cestari; U Filibeck; S Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Calcium channel blockers: effect on morphine-induced hypermotility.

Authors:  M I Martin; I Lizasoain; J C Leza
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  GIRK Channels Modulate Opioid-Induced Motor Activity in a Cell Type- and Subunit-Dependent Manner.

Authors:  Lydia Kotecki; Matthew Hearing; Nora M McCall; Ezequiel Marron Fernandez de Velasco; Marco Pravetoni; Devinder Arora; Nicole C Victoria; Michaelanne B Munoz; Zhilian Xia; Paul A Slesinger; C David Weaver; Kevin Wickman
Journal:  J Neurosci       Date:  2015-05-06       Impact factor: 6.167

4.  The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.

Authors:  J Airio; L Ahtee
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

5.  Heteromers of μ opioid and dopamine D1 receptors modulate opioid-induced locomotor sensitization in a dopamine-independent manner.

Authors:  Yi-Min Tao; Chuan Yu; Wei-Sheng Wang; Yuan-Yuan Hou; Xue-Jun Xu; Zhi-Qiang Chi; Yu-Qiang Ding; Yu-Jun Wang; Jing-Gen Liu
Journal:  Br J Pharmacol       Date:  2017-07-18       Impact factor: 8.739

6.  Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats.

Authors:  A Zharkovsky; J Moisio; T Kivastik; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

7.  Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors.

Authors:  John K Neubert; Heather L Rossi; Jonathan Pogar; Alan C Jenkins; Robert M Caudle
Journal:  Behav Brain Funct       Date:  2007-09-20       Impact factor: 3.759
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.